Pricing Log in Create free account
Friday 6 November 2026 Export GMED’s income statement to Excel — free account

Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

72.24 9.20 −11.30%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Globus Medical, Inc. (GMED) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Globus Medical, Inc. (GMED) trades at a EV/EBITDA of 11.9×. Over the past ten years it has ranged from 8.3× (November 2016) to 37.2× (December 2020); the current reading is higher than 15% of that period. That is in line with the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 15.5× (8.61%)
FY2024 16.9× 2.44%
FY2023 16.5× (27.87%)
FY2022 22.9× (18.01%)
FY2021 27.9× (18.66%)
FY2020 34.4× 38.95%
FY2019 24.7× 34.89%
FY2018 18.3× 0.37%
FY2017 18.3× 75.93%
FY2016 10.4× (11.34%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 11.1× (5.69%)
Jun 2026 11.7× (17.83%)
Mar 2026 14.3× (7.77%)
Dec 2025 15.5× 36.17%
43 more quarters

Against its own ten years

Low 8.3× High 37.2×
Ten-year median 17.9×
Current reading's percentile 15

EV/EBITDA against peers

Company EV/EBITDA
BIO Bio-Rad Laboratories, Inc. compare n/m
GKOS Glaukos Corporation compare n/m
TXG 10x Genomics compare n/m
BIO.B Bio-Rad Laboratories, Inc. compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
GMED Globus Medical, Inc. 11.9×
PODD Insulet Corporation compare 16.1×
PEN Penumbra, Inc. compare 57.3×
BRKR Bruker Corporation compare 66.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on GMED